Laura González García
Member of the Biomarkers and mesothelial pathophysiology research line
Email: lgonzalezg@althaia.cat
ORCID: 0000-0003-2544-8365
Scientific Profile: URECERCA
She is Pharmacist by the University of Salamanca and Specialist in Clinical Chemestry by the Virgen del Rocío University Hospital (HUVR) of Seville where she was recognized as the excellent resident of her promotion (2015-2019).
Since 2016 she has also been a research scientist at the Neurocritical Pathologies Research Group of the Biomedicine Institute of Seville (IBiS), where she started her PhD. In 2019, she did an internship as a co-researcher at the Neurovascular Diseases Research Group of the Vall d’Hebron Institute of Research (VHIR) in Barcelona.
In 2020, she obtained a Cum Laude PhD in Molecular Biology, Biomedicine and Medical Research from the University of Seville. Her doctoral research was related to Neuroscience, focusing mainly on identifying new biomarkers of neuronal injury in neurocritical pathologies such as traumatic brain injury (TBI) and stroke.
Since January 2024, she is also a member of the Neurochemistry and Neurological Diseases Commission of the Spanish Society of Laboratory Medicine (SEQC).
Currently, she is working as Specialist at the Diagnostic Biomedic Department in Althaia (Manresa).
My last happenings:
Cristina Bancells Bau, new member at TR2Lab
The scientific community of TR2Lab welcomes Dr. Cristina Bancells Bau, who joins as a researcher specialized in Mechanisms of tissue repair and regeneration. We are excited to have her talent and dedication in our community!
The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma
The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinomaintegrated care Authors: Núria Moragas, Patricia Fernandez-Nogueira, Leire Recalde-Percaz, Jamie L. Inman, Anna López-Plana, Helga Bergholtz, Aleix Noguera-Castells, Pedro J. del Burgo, Xieng Chen, Therese Sorlie, Pere Gascón, Paloma Bragado, Mina Bissell, Neus Carbó & Gemma Fuster Abstract Breast cancer is the most common cancer in women and the second leading cause of cancer death. DCIS is common and accounts for 20-25% of new breast cancers, with 40,000 predicted in the US in 2020. DCIS lesions vary in [...]
Mariona Espaulella Ferrer has received the Osona Health Award
Mariona Espaulella Ferrer has received the Osona Health Award (Premis sanitat d'Osona) for her article, "Health Care Model for People Living in Nursing Homes Based on Integrated Care." The award recognizes her contribution to improving care for elderly residents through a collaborative health care model. The awarded article demonstrates the benefits of integrating primary care teams with a specialized geriatric team to enhance the health outcomes of nursing home residents. Espaulella's research shows that this approach leads to more personalized care, faster responses to health needs, and improved overall well-being for institutionalized individuals.
PhD Oriol Aguiló has joined as an associate professor at UVIC-UCC
PhD Oriol Aguiló, Internal Medicine specialist, who is currently head of the Emergency Department at Hospital d’Olot i Comarcal de la Garrotxa (Girona) and member of the research line Clinical Research on Prevalent Community Diseases of the Tr2Lab, has joined this academic year 2024-2025 as an associate professor at the UVIC-UCC in the subjects of Exploration II and Clinical Practice I of the Medicine degree.
